Wire Stories
478U.S. Army Corps of Engineers Awards Tetra Tech $200 Million Contract for Architect-Engineer Services
PASADENA, Calif.–(BUSINESS WIRE)–#LEED—Tetra Tech, Inc. (NASDAQ: TTEK) announced today that the U.S. Army Corps of Engineers, Far East District, selected Tetra Tech...
- 731
Wemade Updates ‘Clan Battle’ in MIR M for an Era of Wars!
SEOUL, South Korea–(BUSINESS WIRE)–#KOSDAQ112040–Wemade has updated the ‘Clan Battle’ in MIR M: Vanguard and Vagabond (MIR M), which marks the beginning...
- 524
Leostream Provides Competitive Advantages for ID Networks to Better Support Solutions Built for Highly Complex IT Environments
BOSTON–(BUSINESS WIRE)–Leostream™, the leading provider of enterprise-grade remote access solutions, today announced that ID Networks has turned to the Leostream Platform as...
- 520
Gilat Presents Strong Fourth Quarter and Full Year 2022 Results
Q4 revenue of $73 million, up 8% year over year, GAAP operating income of $6 million and Adjusted EBITDA of $10 million...
- 584
Vast, a Market-Leading Concentrated Solar Power (CSP) Company, to go Public Through Business Combination With Nabors Energy Transition Corp.; Combined Company Expected to be Listed on the New York Stock Exchange
Vast Solar Pty Ltd. (“Vast” or the “Company”) has entered into a Business Combination Agreement with Nabors Energy Transition Corp. (“NETC”). The...
- 670
India Buy Now Pay Later Business Report 2023 Featuring Simpl, ZestMoney, LazyPay, Capital Float, PineLabs, Paytm Postpaid, OlaMoney Postpaid, Amazon Pay Later, & Flipkart Pay Later – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “India Buy Now Pay Later Business and Investment Opportunities Databook – 75+ KPIs on BNPL Market Size, End-Use Sectors, Market...
- 475
Lemonex, mRNA-DegradaBALL vaccine LEM-mR203 clinical phase 1 trial IND submission
SEOUL, South Korea–(BUSINESS WIRE)–Lemonex Inc., a biotechnology company pioneering messenger RNA (mRNA) and siRNA therapeutics based on a novel nanoparticle drug delivery...
- 530
Lemonex, mRNA-DegradaBALL vaccine LEM-mR203 clinical phase 1 trial IND submission
SEOUL, South Korea–(BUSINESS WIRE)–Lemonex Inc., a biotechnology company pioneering messenger RNA (mRNA) and siRNA therapeutics based on a novel nanoparticle drug delivery...
- 511
Lemonex, mRNA-DegradaBALL vaccine LEM-mR203 clinical phase 1 trial IND submission
SEOUL, South Korea–(BUSINESS WIRE)–Lemonex Inc., a biotechnology company pioneering messenger RNA (mRNA) and siRNA therapeutics based on a novel nanoparticle drug delivery...
- 452
China Automotive Millimeter-wave (MMW) Radar Market Report 2022: Quickly Improving Detection Ranges Present Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “China Automotive Millimeter-wave (MMW) Radar Industry Report, 2022” report has been added to ResearchAndMarkets.com’s offering. Automotive radar research: installations surged...
